Carisma Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Carisma Therapeutics's estimated annual revenue is currently $28.1M per year.
- Carisma Therapeutics's estimated revenue per employee is $193,750
- Carisma Therapeutics's total funding is $121M.
Employee Data
- Carisma Therapeutics has 145 Employees.
- Carisma Therapeutics grew their employee count by 13% last year.
Carisma Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Technology & Development Officer; VP, Development | Reveal Email/Phone |
2 | VP, Clinical Operations | Reveal Email/Phone |
3 | VP, Scientific Operations | Reveal Email/Phone |
4 | VP, Discovery and Translational Science | Reveal Email/Phone |
5 | VP, Program and Portfolio Management | Reveal Email/Phone |
6 | Head Investor Relations | Reveal Email/Phone |
7 | VP, Clinical Development | Reveal Email/Phone |
8 | SVP Human Resources | Reveal Email/Phone |
9 | General Counsel and Corporate Secretary | Reveal Email/Phone |
10 | Director Project Management | Reveal Email/Phone |
Carisma Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Carisma Therapeutics?
Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.
keywords:N/A
$121M
Total Funding
145
Number of Employees
$28.1M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Carisma Therapeutics News
Carisma Therapeutics to Present Engineered Cell Therapy Data at The American Association for Cancer Research Annual Meeting ... (PRNewsfoto/...
Carisma (www.carismatx.com ) is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform...
PHILADELPHIA, April 9, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced study findings accepted for virtual presentation at The American Association for Cancer Research (AACR) ...
PHILADELPHIA, March 18, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company spun out of the University of Pennsylvania (Penn) and focused on discovering and developing innovative immunotherapies, announced that the first patient has been dosed in the Phas ...
PHILADELPHIA, March 1, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today the second closing of its Series B equity financing, bringing the total amount raised in this round to $59 millio ...
Other Companies in Philadelphia
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $51.2M | 145 | 4% | N/A |
#2 | $43.1M | 145 | 5% | N/A |
#3 | $46.1M | 146 | N/A | N/A |
#4 | $11M | 146 | 68% | $88M |
#5 | $47.2M | 148 | 6% | N/A |